OCON Healthcare’s mission is to introduce innovative medical solutions that allow women healthier choices while improving their well-being and quality of life.

Since its inception in 2011, OCON has been developing intrauterine products, the IUB™ Ballerine® being the first in market to provide a better fit for women seeking high quality, long lasting, reversible, hormone-free contraception, with a wide women’s health drug-eluting products franchise based on its drug carrier nitinol frame down the line.

The SEAD™, one of OCON’s leading pipeline products, offers a disposable, point of care therapy for abnormal uterine bleeding – a far more comfortable and cost effective alternative for hundreds of thousands of women per year who currently are treated with unhealthy hormones or are sent for ablation therapy which is painful, requires full hospitalization and anesthesia and is costly. If all else fails, these women are subjected to a full hysterectomy (removal of their uterus).

OCON’s technology platform and products are protected by a broad portfolio of patents and trademarks. The private Company, is headquartered in Modiin, Israel with a European Operations in Zürich, Switzerland and a team of specialists and experts spanning all areas of the development chain and commercialization process of medical products.